International Pachyonychia Congenita Research Registry
NCT02321423 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2018-11-21
Summary
International Pachyonychia Congenita Research Registry (IPCRR) is a patient registry for those suffering from Pachyonychia Congenita (PC). PC is an ultra-rare extremely painful skin disorder that causes painful blisters and callus on feet and sometimes hands, thickened nails, cysts and other features. The IPCRR consists of a questionnaire, patient photos, optional physician notes from telephone consultation to validate questionnaire and free genetic testing.
Conditions
- Pachyonychia Congenita
Sponsors & Collaborators
-
Pachyonychia Congenita Project
lead OTHER
Principal Investigators
-
C. David Hansen, MD · Pachyonychia Congenita Project
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-04-30
- Primary Completion
- 2030-12-31
- Completion
- 2030-12-31
Countries
- United States
Study Locations
More Related Trials
-
Scleroderma Registry
NCT00074568 ·Status: COMPLETED
-
Evaluation of Calcinosis in Systemic Sclerosis
NCT03340194 ·Status: COMPLETED
-
National Registry for Ichthyosis and Related Disorders
NCT00074685 ·Status: COMPLETED
-
Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
NCT00904163 ·Status: COMPLETED
-
Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)
NCT02152007 ·Status: COMPLETED ·Phase: PHASE1
-
Identifying Skin Biopsy Sites
NCT01632644 ·Status: COMPLETED
-
Xeroderma Pigmentosum Patient Experiences
NCT01123694 ·Status: UNKNOWN
-
Short-term Function and Pain After Treatment for Dupuytren's Disease
NCT02301078 ·Status: UNKNOWN
-
Photobiomodulation in the Treatment of Hand-foot Syndrome
NCT05337423 ·Status: TERMINATED ·Phase: NA
-
Telangiectatic Palmoplantar Keratoderma in Systemic and Subacute Lupus Erythematosus
NCT04356014 ·Status: UNKNOWN
-
Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
NCT01019148 ·Status: RECRUITING
-
Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.
NCT05168215 ·Status: RECRUITING
-
The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
NCT02887495 ·Status: COMPLETED
-
Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the CARNEY Complex (CNC)
NCT00668291 ·Status: COMPLETED
-
Oral Manifestations of Systemic Sclerosis
NCT02371005 ·Status: TERMINATED ·Phase: NA
-
Lower Urinary Tract Symptoms in Systemic Sclerosis
NCT01971294 ·Status: COMPLETED
-
Delving Into Participation Trends of Scleroderma Clinical Trials
NCT06264492 ·Status: NOT_YET_RECRUITING
-
Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
NCT04115566 ·Status: RECRUITING
-
Assessment of Dermatologists at Skin of Color Clinics
NCT03201029 ·Status: COMPLETED
-
Study of Scaling Disorders and Other Inherited Skin Diseases
NCT00001292 ·Status: COMPLETED
-
Study on the Clinical Features, Comorbidities and Pathologies Associated With Pyoderma Gangrenosum
NCT03636737 ·Status: UNKNOWN
-
Swiss Itch Registry
NCT06120907 ·Status: RECRUITING
-
Prevention and Treatment of Digital Ulcers in Systemic Sclerosis
NCT01836263 ·Status: UNKNOWN
-
Clinical and Biological Characteristics of Hidradenitis Suppurativa
NCT03967600 ·Status: RECRUITING
-
Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment
NCT03262922 ·Status: COMPLETED